This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mégraud, F.
Right arrow Articles by Rossignol, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mégraud, F.
Right arrow Articles by Rossignol, J. F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 1998, p. 2836-2840, Vol. 42, No. 11
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Nitazoxanide, a Potential Drug for Eradication of Helicobacter pylori with No Cross-Resistance to Metronidazole

Francis Mégraud,1,* Alessandra Occhialini,1 and Jean François Rossignol2

Laboratoire de Bactériologie, Hôpital Pellegrin, 33076 Bordeaux Cedex, France,1 and The Romark Institute for Medical Research, Tampa, Florida2

Received 18 March 1998/Returned for modification 17 June 1998/Accepted 20 August 1998

Nitazoxanide, a thiazolide compound, and its desacetyl derivative, tizoxanide, have antimicrobial properties against anaerobic bacteria, as well as against helminths and protozoa. Because the treatment of Helicobacter pylori infection may be jeopardized by metronidazole resistance, nitazoxanide and tizoxanide were tested in vitro against these bacteria. The MICs of these two compounds were determined by agar dilution and were compared to those of metronidazole. Exposure to subinhibitory concentrations of nitazoxanide was also carried out by the method of Szybalski (W. Szybalski and V. Bryson, J. Bacteriol. 64:489-499, 1952). The MICs of nitazoxanide and tizoxanide for 103 strains ranged from 0.25 to 8 µg/ml, with the MIC at which 50% of strains are inhibited (MIC50) being 1 µg/ml and the MIC90 being 4 µg/ml, and no resistant strain was detected, whereas strains resistant to metronidazole were detected. When 10 strains were successively subcultured on medium containing nitazoxanide, no significant change in the MICs of this compound was observed. A pilot study of nitazoxanide for the treatment of H. pylori infection was carried out with 86 patients in association with 20 mg of omeprazole. An eradication rate of 83% (95% confidence interval, 64% to 94%) was obtained in a per-protocol analysis in the group receiving 1 g of nitazoxanide orally twice daily, and a few side effects were observed. The failures could not be explained by the selection of resistant strains since the MICs of nitazoxanide were similar for six pairs of isolates (proven to be the same strain by random amplified polymorphic DNA analysis in four cases) cultured before and after the treatment failure. Nitazoxanide exhibits good antimicrobial activity against H. pylori without the problem of acquired resistance which is encountered with metronidazole and has been demonstrated to have a satisfactory effect in a dose-ranging pilot study. It is therefore a good candidate to be included in treatment regimens aimed at the eradication of H. pylori.

* Corresponding author. Mailing address: Laboratoire de Bactériologie, Hôpital Pellegrin, 33076 Bordeaux Cedex, France. Phone: 33 5 56 79 59 10. Fax: 33 5 56 79 60 18. E-mail: francis.megraud{at}chu-aquitaine.fr.

Antimicrobial Agents and Chemotherapy, November 1998, p. 2836-2840, Vol. 42, No. 11
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Vets, E., Rossignol, J.-F., Jackson, A. S. (2009). Effects of nitazoxanide on pharmacokinetics and pharmacodynamics of a single dose of warfarin. Am J Health Syst Pharm 66: 838-842 [Abstract] [Full Text]  
  • Sterk, M., Muller, J., Hemphill, A., Muller, N. (2007). Characterization of a Giardia lamblia WB C6 clone resistant to the isoflavone formononetin. Microbiology 153: 4150-4158 [Abstract] [Full Text]  
  • Muller, J., Sterk, M., Hemphill, A., Muller, N. (2007). Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole. J Antimicrob Chemother 60: 280-287 [Abstract] [Full Text]  
  • Muller, J., Wastling, J., Sanderson, S., Muller, N., Hemphill, A. (2007). A Novel Giardia lamblia Nitroreductase, GlNR1, Interacts with Nitazoxanide and Other Thiazolides. Antimicrob. Agents Chemother. 51: 1979-1986 [Abstract] [Full Text]  
  • Hoffman, P. S., Sisson, G., Croxen, M. A., Welch, K., Harman, W. D., Cremades, N., Morash, M. G. (2007). Antiparasitic Drug Nitazoxanide Inhibits the Pyruvate Oxidoreductases of Helicobacter pylori, Selected Anaerobic Bacteria and Parasites, and Campylobacter jejuni. Antimicrob. Agents Chemother. 51: 868-876 [Abstract] [Full Text]  
  • Muller, J., Ruhle, G., Muller, N., Rossignol, J.-F., Hemphill, A. (2006). In Vitro Effects of Thiazolides on Giardia lamblia WB Clone C6 Cultured Axenically and in Coculture with Caco2 Cells. Antimicrob. Agents Chemother. 50: 162-170 [Abstract] [Full Text]  
  • Guttner, Y., Windsor, H. M., Viiala, C. H., Dusci, L., Marshall, B. J. (2003). Nitazoxanide in Treatment of Helicobacter pylori: a Clinical and In Vitro Study. Antimicrob. Agents Chemother. 47: 3780-3783 [Abstract] [Full Text]  
  • Loughlin, M. F., Ala'Aldeen, D. A., Jenks, P. J. (2003). Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice. J Antimicrob Chemother 51: 367-371 [Abstract] [Full Text]  
  • Sisson, G., Goodwin, A., Raudonikiene, A., Hughes, N. J., Mukhopadhyay, A. K., Berg, D. E., Hoffman, P. S. (2002). Enzymes Associated with Reductive Activation and Action of Nitazoxanide, Nitrofurans, and Metronidazole in Helicobacter pylori. Antimicrob. Agents Chemother. 46: 2116-2123 [Abstract] [Full Text]  
  • Adagu, I. S., Nolder, D., Warhurst, D. C., Rossignol, J.-F. (2002). In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J Antimicrob Chemother 49: 103-111 [Abstract] [Full Text]  
  • Jenks, P. J., Ferrero, R. L., Tankovic, J., Thiberge, J.-M., Labigne, A. (2000). Evaluation of Nitrofurantoin Combination Therapy of Metronidazole-Sensitive and -Resistant Helicobacter pylori Infections in Mice. Antimicrob. Agents Chemother. 44: 2623-2629 [Abstract] [Full Text]  
  • McVay, C. S., Rolfe, R. D. (2000). In Vitro and In Vivo Activities of Nitazoxanide against Clostridium difficile. Antimicrob. Agents Chemother. 44: 2254-2258 [Abstract] [Full Text]  
  • Giacometti, A., Cirioni, O., Barchiesi, F., Ancarani, F., Scalise, G. (2000). Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. J Antimicrob Chemother 45: 453-456 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»